Stocks / NASDAQ / Design Therapeutics Inc.

Design Therapeutics Inc.

Our Opinion

Design Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“We have observed good biodistribution and bioavailability for FA GeneTACs in multiple animal species, where they reached therapeutically relevant concentrations in the most affected organs such as heart, brain, muscle and spinal cord.” (Page 111) Read the full document

Company Description

Design Therapeutics Inc is a biopharmaceutical company. The Company is focused on developing disease-modifying small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to target the underlying cause of inherited nucleotide repeat expansion diseases.

Company Website: